On Monday, the U.S. Court of Appeals for the Third Circuit in Washington, D.C., ruled against Merck & Co., rejecting its ...

With its ascent seemingly unstoppable in the last few years, automated cell therapy manufacturer Cellares is facing some ...

HHS Secretary Robert F. Kennedy Jr. has joined President Donald Trump in a renewed effort to challenge how the United States ...

Hansa has operated as a commercial-stage drugmaker since 2020, when the European Union cleared the way for imlifidase for ...

Eli Lilly is drawing attention to a lifelong journey of obesity struggles in its new campaign linked to GLP-1 Medicare access ...

Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the executive in ...

Move over, Hollywood—the real stars of the show are the ones helping patients in hospitals across the country.  | Education ...

Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove its mettle as a ...

If at first you don’t succeed in gene therapy, then try, try again. | If at first you don’t succeed in gene therapy, then try ...

For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be on the horizon ...

After more than 10 years in development, Regeneron secured a landmark approval for its monoclonal antibody garetosmab, now ...

Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs, ...